Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 28, 2015; 21(8): 2323-2335
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2323
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2323
Figure 6 The effect of fibronectin is ameliorated after profilin-1 silencing.
A: SGC-7901 cells with and without profilin-1 (PFN1) silencing were seeded onto media with or without fibronectin (FN) (10 μg/mL) for 24 h. The expression of phosphorylated focal adhesion kinase (FAK) was evaluated by Western blot; B: SGC-7901 cells with and without PFN1 silencing were seeded on media with or without FN (10 μg/mL) at the indicated time points. Cell proliferation levels were measured using the cell counting kit-8 at 12, 24 and 48 h. The optical density (A) represents the proliferative characteristics of the treated cells; C: SGC-7901 cells with and without PFN1 silencing were suspended in media with or without FN (10 μg/mL) and seeded onto transwell plates. The cell migration was assessed 24 h later. For the invasion assays, the cells were seeded onto BD Matrigel invasion chambers. aP < 0.05, bP < 0.01 vs other groups. GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; Si: Silencing.
-
Citation: Cheng YJ, Zhu ZX, Zhou JS, Hu ZQ, Zhang JP, Cai QP, Wang LH. Silencing profilin-1 inhibits gastric cancer progression
via integrin β1/focal adhesion kinase pathway modulation. World J Gastroenterol 2015; 21(8): 2323-2335 - URL: https://www.wjgnet.com/1007-9327/full/v21/i8/2323.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i8.2323